Akèy › Rezistans Insilin › Maryland
Etid klinik pou Rezistans Insilin nan Maryland
7 etid pou Rezistans Insilin ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial
- National Institute of Aging, Clinical Research Unit, Baltimore
Ap rekrite
Laj 55 a 100 · Tout sèks · Mizajou Oct 2, 2026 · NCT06274749Tirzepatide for Treatment of CCCA
- Johns Hopkins Outpatient Center, Baltimore
- Medical Pavilion at Howard County, Columbia
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 23, 2026 · NCT07734870Taste Bud-Derived Stem Cells in Humans
- National Institute of Aging, Clinical Research Unit, Baltimore
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 120 · Tout sèks · Mizajou Sep 16, 2026 · NCT03366168Risk-informed Shared-decision Making Engagement Strategy for Patients With Prediabetes
- Johns Hopkins Community Physicians Frederick, Frederick
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Aug 28, 2026 · NCT07553325Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Baltimore VA Medical Center Univ of Maryland, Baltimore
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Aug 28, 2026 · NCT07599982Genetic Studies of Insulin and Diabetes
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
6 Months – 120 Years · Tout sèks · Mizajou Aug 24, 2026 · NCT00001987Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Aug 18, 2026 · NCT05470504Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.